Technical / White Paper

Supply Chain Solutions for the Growing Orphan Drug Market

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by Marken, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Supply Chain Solutions for the Growing Orphan Drug Market

Marken recognizes the pharma industry’s increased focus on rare disease treatments and the complexity of safely transporting them to patients residing in multiple countries, each with its own unique customs and regulatory requirements. Marken’s Direct to Patient service utilizes its team of experts in customs and trade compliance along with its extensive network of depot facilities and strategically located distribution centers throughout the world to provide timely global packaging, transport and tracking of orphan drug materials within regulatory, temperature and time constraints.

Latest content from Marken

show more

How personalized medicines are disrupting the supply chain

Content provided by Marken

How personalized medicines are disrupting the supply chain

Sponsors for a Phase 2 clinical trial needed an expensive, time-sensitive therapy transported to investigator sites at -80º C. Further, when reaching out to cryogenic shipper rental companies, the sponsor found they often transport regionally and do not...

Marken Advances Critical Supply Chain

Content provided by Marken

Marken Advances Critical Supply Chain

Cell and gene therapies are the next-generation healthcare protocols, and the human trials into their efficacies are rising. An advanced supply chain solutions provider is the key to success.

Related resources from Marken

Show more

Supplier info centre